Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Was that addressed to me?
Perhaps reading the stickies and press releases from the last year will put you more at ease. Since you don't know a thing about the company you don't know enough to think that it is a scam. Seems that due diligence is in order on your part.
HemaCare Announces OneBlood Exercises Second Investment Tranche Option
Business WireJanuary 8, 2018
LOS ANGELES--(BUSINESS WIRE)--
HemaCare Corporation (HEMA), a leading provider of human-derived primary blood cells and tissues for biomedical research, has announced a second tranche investment, effective December 28, 2017, by a wholly-owned subsidiary of OneBlood, Inc., a not-for-profit blood center based in Florida. Under the terms of the agreement signed January 6, 2017, OneBlood is purchasing an additional 363,786 shares at $3.44 per share.
“OneBlood is an industry-leading blood center that is known for its innovative and progressive approaches. Based on HemaCare’s sustained outstanding performance, OneBlood’s wholly-owned subsidiary exercised their option to make the second tranche investment,” said Pete van der Wal, Chief Executive Officer for HemaCare. “In addition, both parties continue performing according to the terms of the Sales and Distribution Agreement executed in January, 2017,” said van der Wal.
“The partnership with HemaCare is mutually beneficial,” said Mr. Scholl, Chief Executive Officer for OneBlood. “We are excited to be a part of an initiative that is helping provide scientists and clinical researchers with what they need to find the next generation of medical cures,” said Scholl.
I'd like to see ABHI have their software on one server by the end of February. One paying client. ABHI needs to show that what they gave is transformative and wanted in the marketplace. Then we can discuss EPA and Deutsche Bank. I deal with realities, not fantasies.
Saw these two quotes on another iHub board that I thought were particularly relevant to shareholders of ABHI:
"The stock market is a device for transferring money from the impatient to the patient" — Warren Buffett
"The Big Money is not in the buying and the selling but in the waiting" — Charlie Munger
"I'm stuck but hell in legit bomb that will explode next week or after"
Don't go out on too much of a limb as to when the stock will explode. Actually, I think that's the concern.
Even our greatest cheerleader is discouraged. May be time to buy more.
Good to hear that things are moving along. People get tired of holding for more than a few weeks and move on. I've held stocks for years before they start moving.
You feel "stuck" in ABHI rather than glad to be in it?
Terrible investment strategy, if you can even call what you are suggesting a strategy. So one sells now and there's an announcement on Monday and the stock goes to .0014. Or it can go to .0003 and you can buy more shares there after having sold at .0007. You can roll the dice and see which works out to your advantage. But it is dice rolling.
In the same way that Sessions was not in agreement with Trump's desire for him not to recuse himself from the Russian probe.
This administration is from an alternate universe. It's hard to know why anything with them. When Sessions was before the Senate committee deciding on whether or not to approve his appointment as AG he said he wouldn't muck with the MJ ruling from the Obama administration. Trump said the same thing during his campaign, that regulation of MJ should be done at the State level. And here we are.
It's up .18 or .51% after hours. That was an error on Yahoo you saw.
http://www.nasdaq.com/symbol/mjx/after-hours
Trump is set up to keep a campaign promise which Sessions just broke for him. Also, Trump could challenge Sessions to avoid a confrontation between his administration and Congress. I hope.
Understandably, he wants to get a functioning, revenue generating company going. Once he does that he'll have the bandwidth to focus on share structure. This is the same answer he gave a few weeks ago when he was asked the same question. Saying that there are multiple options includes not only share buy-back (which necessitates having the corporate cash to do so) but also includes doing a reverse split. I know many people disagree with me about the reverse split, but 2.7B shares outstanding is far too many to attract more investors to our stock. Many people are hesitant to invest in a stock at .01 or .05, never mind at .0008. But I would wait until we can get a high enough share price to get over $1 post split.
1 cent or more if they make money. It's not enough to have deals. There needs to be positive outcomes as a result of those deals. The more they keep diluting the more money they will need to make to justify a share price of a few pennies. When they become profitable would love to see a reverse split.
Apples and oranges. What do MJ stocks have to do with ABHI? MJ stocks have been on a tear and were due for a correction and in addition our esteemed AG's announcement today scared a lot of people into selling their shares. You're happy that ABHI has been more or less flat for the past month?
Sold 500K shares today at .0155 and then because the price kept dropping bought back 400K shares at .0131. Let's see if people wake up to the difference between MJ/THC and CBD tomorrow and we go on another green streak.
As far as I know, that option to buy more at 3.44 was not executed.
Yeah. You're an amazing dancer.
Great. I wonder if ABHI gets all $500/200 or if a percentage goes to Kaseya, since we don't know about their financial agreement.
Thanks. I'll try that. Sorry to take focus away from
$UBQU !!
Does anyone else have a hijack of your Android phone when going to investors hub in Chrome? I get a web page that comes up and says either Google rewards or Amazon awards. It happens a few times a day.
Not in the video and not in the link to the press release. You made it up.
The financial arrangement between Kaseya and AmbiCom is unknown.
We need to get current and demonstrate that we have customers and revenues. All the relationships that ABHI has put and is putting into place need to bear fruit. Press releases, videos and promises of the CEO are all great, but it is positive financial results that will propel the share price upward. The CEO of course knows this and has concrete plans to make it happen. Now to let it unfold.
Let me see if I can summarize your response. You have no link to substantiate the nature of a financial agreement between ABHI and Kaseya. You made it up. Is that correct?
"Didn't Kevin say that was the intent as opposed to an agreement with Kaseya? Do you have a link where ABHI or Kaseya indicate that the financial agreement is as you stated?"
Can you answer that question?
Didn't Kevin say that was the intent as opposed to an agreement with Kaseya? Do you have a link where ABHI or Kaseya indicate that the financial agreement is as you stated?
What are the revenue and profit sharing terms of the contract between ABHI and Kaseya?
How did you come up with a pps of .10? What data did you use?
Let's keep the board on topic. If you want to talk about another company please do so on their board.
$UBQU
I doubt it. I think it's his self-righteous point of view.
His points about the name of the company and that it's non-reporting were ridiculous. As has been pointed out, he knows nothing about the crypto software so the name is perfectly fine. Maybe it was because it was hard for him to say. Not the most fluid speaker I've ever heard.
About non-reporting - many of the stocks I own are non-reporting since they want to save money. I've made a lot of money on those stocks. It's not a reason to not own a stock.
UBQU does need to be careful about their claims on their website. They are on the edge of what's permissible but if they are told by the FDA to tone it down they will make the necessary changes.
The other thing he said that was bizarre was that the CBD market is tiny and so being Forbes #5 in a tiny market isn't saying much. But it's an exponentially growing market so his point was another indication of his ignorance.
Let's be clear that there is a difference between MJ bill passage to make marijuana legal across the U.S. (highly unlikely under this administration) and the ability to continue selling CBD as a supplement (much more likely). MJ has psychoactive properties as we all know, CBD does not which probably due to pharmaceutical company lobbying has DEA with its head up its butt about it, regardless of a virtually zero level of THC.
It doesn't matter if crypto currencies drop like a rock. If people can trade them, i.e., people assign a value to them like our ancestors did with beads and shells, software will still be needed to allow for that trading. UBQU will need to demonstrate the competitive advantage they bring to the crypto software market given the number of competitors in that space.
I think it's a lot healthier for the stock and its crypto software if there's NOT a website that looks like theirs. How did that happen? Is that other website the creators of the software that UBQU will be buying or licensing? Lots of unknowns, including when will Cryptobuy go live.
Very reasonable.
What are you talking about?
So you see UBQU having a market cap of 1 to 2 billion dollars. How did you come up with that market cap? Current market cap is about $10M. How long do you think it will take to get to $1B or $2B?
The wheels of government turn slowly, if at all. There's a lot of money to be made regardless of the long-term outcome. That's not investment advice, just my opinion.